RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.765
EU - Europa 6.078
AS - Asia 5.205
SA - Sud America 640
Continente sconosciuto - Info sul continente non disponibili 230
AF - Africa 114
OC - Oceania 5
Totale 26.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.499
GB - Regno Unito 1.848
SG - Singapore 1.394
IT - Italia 1.375
CN - Cina 1.323
HK - Hong Kong 764
SE - Svezia 629
VN - Vietnam 567
BR - Brasile 470
DE - Germania 434
FI - Finlandia 345
BD - Bangladesh 324
NL - Olanda 320
RU - Federazione Russa 271
FR - Francia 246
UA - Ucraina 233
TR - Turchia 198
CA - Canada 144
IN - India 136
KR - Corea 106
BG - Bulgaria 94
ID - Indonesia 71
MX - Messico 53
AR - Argentina 52
IQ - Iraq 45
BE - Belgio 40
JP - Giappone 38
CZ - Repubblica Ceca 31
PL - Polonia 30
ZA - Sudafrica 30
ES - Italia 28
IE - Irlanda 26
UZ - Uzbekistan 24
AE - Emirati Arabi Uniti 23
CO - Colombia 23
IR - Iran 23
PK - Pakistan 23
AT - Austria 22
CL - Cile 22
EC - Ecuador 21
LT - Lituania 20
MA - Marocco 20
VE - Venezuela 18
MY - Malesia 17
KE - Kenya 16
BZ - Belize 15
PH - Filippine 15
AZ - Azerbaigian 14
CR - Costa Rica 14
PY - Paraguay 14
EG - Egitto 13
JM - Giamaica 13
EU - Europa 11
TN - Tunisia 11
RO - Romania 10
SA - Arabia Saudita 10
CY - Cipro 9
DK - Danimarca 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
CH - Svizzera 8
NP - Nepal 8
RS - Serbia 8
AL - Albania 7
DZ - Algeria 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
PS - Palestinian Territory 7
TH - Thailandia 7
BO - Bolivia 6
BY - Bielorussia 6
EE - Estonia 6
GR - Grecia 6
OM - Oman 6
UY - Uruguay 6
KG - Kirghizistan 5
AU - Australia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
QA - Qatar 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
SN - Senegal 2
SV - El Salvador 2
Totale 25.792
Salva come PNG Salva come JPEG
Città #
Ashburn 1.639
Southend 1.357
Fairfield 1.240
Santa Clara 1.055
Singapore 884
Woodbridge 804
Hong Kong 751
Chandler 637
San Jose 605
Houston 588
Ann Arbor 507
Seattle 479
Jacksonville 428
Wilmington 425
Dearborn 423
Cambridge 390
Nyköping 350
Hefei 331
Council Bluffs 303
Beijing 294
Amsterdam 248
Helsinki 241
New York 240
London 232
Modena 206
Los Angeles 198
Ho Chi Minh City 186
Chicago 177
Milan 137
The Dalles 127
Hanoi 126
Izmir 105
San Diego 104
Seoul 102
Munich 93
Sofia 90
Buffalo 88
Princeton 87
Eugene 82
Fremont 75
Moscow 73
Lauterbourg 71
Rome 69
Columbus 63
Dallas 61
Bremen 55
Boardman 53
Shanghai 52
São Paulo 51
Orem 49
Jakarta 46
Salt Lake City 42
Bologna 41
Des Moines 41
Frankfurt am Main 36
Toronto 35
Brussels 33
Tokyo 32
Redwood City 31
Atlanta 30
Da Nang 29
Ottawa 28
Boston 27
Montreal 26
Naples 25
Chennai 24
Turku 24
Washington 24
Paris 23
Haiphong 22
Tashkent 22
Warsaw 22
Brooklyn 21
San Francisco 21
Tampa 21
Denver 20
Dublin 20
Phoenix 20
Elk Grove Village 19
Las Vegas 19
Philadelphia 19
Mexico City 17
Detroit 16
Guangzhou 16
Johannesburg 16
Rio de Janeiro 16
Stockholm 16
Belize City 15
Miano 15
Nairobi 15
Palermo 15
Reggio Emilia 15
Albuquerque 14
Kunming 14
Baghdad 13
Manchester 13
Miami 13
Mumbai 13
Nanjing 13
Newark 13
Totale 18.152
Salva come PNG Salva come JPEG
Nome #
B cells and herpesviruses: a model of lymphoproliferation 463
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 457
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 454
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 438
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 418
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 402
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 398
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 393
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 388
Mucorales-specific T cells in patients with hematologic malignancies 384
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 380
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 377
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 377
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 375
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 372
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 370
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 369
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 364
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 363
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 363
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 360
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 358
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 358
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 358
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 352
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 350
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 350
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 334
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 327
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 324
Parvoviruses in blood donors and transplant patients, Italy 324
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 322
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 321
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 320
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 318
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 314
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 314
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 313
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 312
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 301
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 300
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 297
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 296
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 295
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 292
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 291
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 290
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 290
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 286
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 285
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 283
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 281
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 279
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 276
How I treat HHV8/KSHV-related diseases in posttransplant patients. 273
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 273
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 271
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 265
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 263
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 261
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 259
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 247
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 247
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 247
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 242
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 230
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 229
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 226
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 222
Pneumonia in acute leukaemia:blossoming culprits 221
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 216
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 215
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 212
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 210
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 208
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 208
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 201
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 200
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 193
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 188
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 185
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 184
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 173
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 164
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 163
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 163
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 148
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 137
The dynamic functions of IRF4 in B cell malignancies 117
Totale 26.037
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.899
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.231 0 0 0 98 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20253.847 155 49 76 279 701 541 309 231 431 151 385 539
2025/20267.199 611 367 609 647 969 498 882 332 726 620 540 398
2026/20271.484 180 458 458 388 0 0 0 0 0 0 0 0
Totale 26.037